|
KR20190044006A
|
|
An antibody against MERS-CoV and method of determining titration for antibody to MERS-CoV using the same
|
|
US2017313771A1
|
|
Antibody for Recognizing Specific Motif of WLS Protein, and Pharmaceutical Composition Comprising Same
|
|
KR20120093002A
|
|
Method for diagnosing cancer and diagnosis kit using measurement of nk cell activity
|
|
KR100625858B1
|
|
Pharmaceutical composition comprising pkck2 inhibitor and anti-cancer agent
|
|
KR20060055315A
|
|
Regulation of pro-caspase-2 activation by phosphorylation of pro-caspase-2
|
|
WO2005108423A1
|
|
Novel peptides conferring environmental stress resistance and fusion proteins including said peptides
|
|
KR100565764B1
|
|
Novel peptides conferring environmental stress resistance and fusion proteins including said peptides
|
|
KR100450133B1
|
|
Stabilized human growth hormone fusion protein
|
|
EP1451217A1
|
|
Novel peptides conferring environmental stress resistance and fusion proteins including said peptides
|
|
KR20030085417A
|
|
Novel Peptides With Chaperone Activity
|
